Austrian Scientist Takes the Pioneer Step And Invents The Vaccine For Common Cold And Flu

The war between humans and common cold and flu is tough since hundreds of years. But medicines are not the solution as much as a vaccine is. Now, instead of a cure, humans will be looking for prevention through a powerful and effective vaccine.

An Austrian scientist has made this dream possible for the humanity by registering a patent vaccine for the common cold. It will be in the market in less than a decade. Rudolf Valenta, an allergy expert at the Medical University of Vienna is vehemently researching for the virus called "rhinovirus" responsible for runny-nose and sore throat, reports Science Alert.

The common cold has so many different strains which make it a difficult to treat or avoid sickness. Valenta is sure that his decades' long research on cold and flu virus will bring positive results and he will be able to find ways to block rhinovirus for all the good.

Valenta was talking to Katie Forster at The Independent when he cleared that this is no resolution as the study is based on an old-established rule that activates body's own immune system to combat the virus. The key in this all is to let the immune system attack the rhinovirus in a way that is efficient.

Instead of making the immune system attack the inner center of the virus and try or fail to break it, the vaccine directs the immune system to attack to the outer shell of the virus.   

Valenta maintains this part the biggest challenge that directly deals with the virus and prevents it from spreading. With its 99 strains and ability to mutate away from the immune system, achieving a success in combating the virus is the real challenges. Even the diversity of strains is not an issue as much as hitting the right spot of the virus is important, concluded Valenta.

The patent application is now in the possession of European Patent Register for the registration and mentions more than 200 scientific researches as a basis for the new technology.